Truist analyst Andrew Jeffrey lowered the firm’s price target on HireRight to $9 from $18 and keeps a Hold rating on the shares. The analyst is citing slowing structural screening demand, noting that while the company’s Q3 print and guide likely de-risks the outlook, he remains sidelined as a return to post-pandemic employment velocity is unlikely. Jeffrey also cuts his HireRight FY22 EBITDA view to $184M from $206M and his FY23 view to $179M from $243M.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HRT:
